THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. : Entry into a Material Definitive Agreement, Other Events (form 8-K)

Item 1.01 Entry into a Material Definitive Agreement

On February 17, 2023, Therapeutic Solutions International, Inc. and Veltmeyer Institute for Advanced Biologics, LLC, entered into an exclusive patent license agreement for Right to Try, emergency Investigational New Drug ("IND"), and/or Expanded Access use within the field of brain and lung for those conditions that are applicable included here in exhibit 10.1. In exchange TSOI has received 30% of Veltmeyer Institute Management Company, LLC.

Item 8.01 Other Events.

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference including reference to exhibits.

© Edgar Online, source Glimpses